Chat with us on WhatsApp
1

There is a condition affecting men that is rarely discussed openly — not in clinical waiting rooms, not among friends, and certainly not at the dinner table. Yet it affects an estimated 3-9% of adult men, causes significant physical discomfort, and has a profound psychological impact on relationships and self-confidence. It is called Peyronie’s disease — and most men who have it suffer quietly for months or years before seeking help.

The silence around Peyronie’s disease is partly cultural and partly born from the mistaken belief that nothing can be done. Both assumptions are wrong. Peyronie’s disease is a recognised medical condition with well-established treatment options — and the earlier it is evaluated, the more options are available.

What Is Peyronie’s Disease?

Peyronie’s disease is a condition in which fibrous scar tissue (called a plaque) forms within the tunica albuginea — the tough, elastic sheath surrounding the erectile chambers of the penis. This plaque does not stretch during erection the way normal tissue does, causing the penis to bend, curve, shorten, narrow, or develop an indentation at the site of the scar.

The condition is not congenital — men are born with a normal penis that changes over time due to scar formation. It is named after French physician Francois de la Peyronie, who described it in 1743. Despite its long recognition, it remains significantly underdiagnosed and under-discussed.

What Causes Peyronie’s Disease?

The exact cause is not always identifiable, but the current best understanding is that Peyronie’s disease develops following minor, often unnoticed trauma to the erect penis — typically during sexual activity. In genetically predisposed individuals, the normal wound healing response goes awry — instead of resolving, the inflammatory response leads to excessive collagen deposition and scar formation within the tunica.

Contributing factors include:

  • Genetic predisposition: Men with Dupuytren’s contracture (palmar fibrosis) have a significantly higher risk of Peyronie’s disease — suggesting a shared underlying fibrotic tendency.
  • Age: More common in men above 40, though it can occur at any age.
  • Diabetes and hypertension: Both associated with higher rates of Peyronie’s disease, possibly through effects on tissue healing and vascularity.
  • Prior pelvic surgery or radiation: Including radical prostatectomy.
  • Certain medications: Rare associations have been reported with some drugs.

The Two Phases of Peyronie’s Disease

Active (Acute) Phase

The initial phase — typically lasting 6-18 months — during which the plaque is forming. This phase is characterised by penile pain (particularly during erection), progressive change in curvature or deformity, and psychological distress. This is the phase where anti-inflammatory and collagen-modifying treatments are most useful — intervention during the active phase may limit the extent of final scarring.

Stable (Chronic) Phase

Once the plaque has stabilised and curvature and pain are no longer changing — usually after 12-18 months — the disease has entered its stable phase. Pain typically resolves in the stable phase. The deformity, however, remains — and if it is causing difficulty with intercourse or significant psychological distress, surgical correction becomes an option.

How Peyronie’s Disease Affects Men

The impact of Peyronie’s disease extends well beyond the physical. Studies consistently show high rates of:

  • Difficulty or inability to have sexual intercourse due to curvature or narrowing.
  • Erectile dysfunction — both directly (from plaque-related vascular impairment) and psychologically (from performance anxiety).
  • Relationship strain and partner distress.
  • Depression, anxiety, and reduced self-esteem.
  • Avoidance of sexual activity and intimate relationships.

These psychological consequences are just as real and just as treatable as the physical deformity — and a compassionate, comprehensive andrological consultation addresses both dimensions.

Treatment Options

Active Phase: Non-Surgical Management

  • Oral agents: Vitamin E and potassium para-aminobenzoate (Potaba) have been used historically with limited evidence. Colchicine and pentoxifylline are used in some centres.
  • Intralesional injections: Collagenase Clostridium histolyticum (CCH) injections directly into the plaque — approved in several countries for stable Peyronie’s with significant curvature — can reduce deformity in selected patients.
  • Verapamil injections and interferon injections: Used in some centres during the active phase to modulate the fibrotic process.
  • Penile traction therapy: Mechanical stretching devices used regularly can reduce curvature and help preserve penile length during the active phase.

Stable Phase: Surgical Options

Surgical correction is the most reliably effective treatment for significant stable Peyronie’s disease causing intercourse difficulties:

  • Plication (Nesbit procedure): Shortening the unaffected longer side of the penis to straighten the erection. Simpler, faster, and associated with fewer complications — but results in some penile shortening. Best for mild to moderate curvature with adequate penile length.
  • Plaque incision/excision and grafting: The plaque is incised or excised and a graft placed to correct the deformity. Better for more severe curvature or complex deformities. Preserves or restores length but carries higher risk of post-operative ED.
  • Penile implant with intraoperative modelling: For men with both significant Peyronie’s deformity and ED — the implant corrects both problems simultaneously. The implant is placed and then manually modelled to correct curvature. Often the most elegant combined solution.

Living With Peyronie’s Disease

Many men with Peyronie’s disease continue to have satisfying sexual relationships — particularly after treatment. The condition does not affect sensation, orgasm, ejaculation, or fertility. With the right combination of medical management, psychological support, and — where needed — surgical correction, most men achieve significant improvement in both physical function and quality of life.

Dr. Prarthan Joshi at Zydus Hospitals, Ahmedabad, offers comprehensive evaluation and treatment for Peyronie’s disease — from non-surgical management during the active phase to surgical correction in the stable phase. Consultations are completely confidential. For expert Peyronie’s Disease Treatment in Ahmedabad, you do not have to manage this condition alone.